Yahoo India Web Search

Search results

  1. www.forbes.com › profile › satish-mehtaSatish Mehta - Forbes

    Mar 6, 2018 · Pharma distributor's son Satish Mehta founded and runs privately held generics maker Emcure Pharmaceuticals. He started Emcure in Pune city as a contract manufacturer for multinationals in 1981...

  2. www.emcure.com › leadership › satish-ramanlal-mehtaSatish Ramanlal Mehta

    Satish Mehta is the first-generation entrepreneur and visionary who started Emcure in 1981 with the purpose to provide affordable and high quality healthcare to patients to significantly improve their lives.

  3. Oct 4, 2017 · About Satish Mehta & family. Pharma distributor's son Satish Mehta founded and runs Emcure Pharmaceuticals, which has private equity firm Bain Capital as an investor. Mehta started the...

  4. Samit Satish Mehta Whole-time Director. Palamadai Sundararajan Jayakumar Independent Director. Samonnoi Banerjee Non Executive Director. Shailesh Kripalu Ayyangar Independent Director. Vijay Keshav Gokhale Independent Director. Vidya Rajiv Yeravdekar Independent Director. Senior Management Balaji Aravamuthan President IT and Digital. Rajesh Nair President – HR.

  5. Aug 19, 2021 · Second-generation entrepreneur Satish Mehta started Emcure Pharmaceuticals decades before ‘Made in India’ or ‘Build in India’ became catchphrases.

  6. 4 days ago · Those selling shares in the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.85 per cent stake in the company and BC Investments owns a 13.07 per cent stake. Advertisement. Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.

  7. Emcure Pharmaceuticals was established in 1981 by Satish Mehta, who began the company with a bank loan of ₹ 3 lakh (about US$35,000 then) after graduating from IIM-A. [9] In 2006, Emcure signed license agreements with Bristol-Myers Squibb for Atazanavir [10] and Gilead Sciences for Tenofovir as part of their Global Access Programs.

  8. Aug 9, 2021 · Satish Mehta, founder and CEO of Emcure Pharmaceuticals, says that while he is satisfied with the primary outcome on safety of the vaccine, he will soon submit the data with CDSCO and apply for next phase trials.

  9. Jul 27, 2021 · Established in 1981, the firm was founded by Mr. Satish Mehta who spotted an opportunity in contract manufacturing pharmaceuticals for MNCs. Emcure is ranked as the 12 th largest pharma company in India (AIOCD-AWACS MAT Mar 21).

  10. 2 days ago · Those selling shares in the OFS include promoter Satish Mehta and investor BC Investments IV Ltd, an affiliate of US-based private equity major Bain Capital. Currently, Satish Mehta holds a 41.85 per cent stake in the company and BC Investments owns a 13.07 per cent stake. Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.

  1. People also search for